Regeneron Pharmaceuticals Inc (REGN)
982.29
+14.31
(+1.48%)
USD |
NASDAQ |
May 17, 16:00
982.60
+0.31
(+0.03%)
After-Hours: 20:00
Regeneron Pharmaceuticals Cash and Short Term Investments (Annual): 10.84B for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.84B |
| December 31, 2022 | 7.742B |
| December 31, 2021 | 5.695B |
| December 31, 2020 | 3.587B |
| December 31, 2019 | 3.214B |
| December 31, 2018 | 2.810B |
| December 31, 2017 | 1.410B |
| December 31, 2016 | 1.039B |
| December 31, 2015 | 1.045B |
| December 31, 2014 | 900.48M |
| December 31, 2013 | 693.98M |
| December 31, 2012 | 308.10M |
| December 31, 2011 | 526.94M |
| December 31, 2010 | 249.37M |
| December 31, 2009 | 341.33M |
| December 31, 2008 | 474.75M |
| December 31, 2007 | 766.46M |
| Date | Value |
|---|---|
| December 31, 2006 | 459.28M |
| December 31, 2005 | 298.54M |
| December 31, 2004 | 295.98M |
| December 31, 2003 | 293.77M |
| December 31, 2002 | 264.27M |
| December 31, 2001 | 385.08M |
| December 31, 2000 | 117.61M |
| December 31, 1999 | 66.20M |
| December 31, 1998 | 19.80M |
| December 31, 1997 | 28.90M |
| December 31, 1996 | 34.50M |
| December 31, 1995 | 32.70M |
| December 31, 1994 | 23.60M |
| December 31, 1993 | 12.50M |
| December 31, 1992 | 16.40M |
| December 31, 1991 | 26.20M |
| December 31, 1990 | 21.80M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
3.214B
Minimum
2019
10.84B
Maximum
2023
6.217B
Average
5.695B
Median
2021
Cash and Short Term Investments (Annual) Benchmarks
| Vertex Pharmaceuticals Inc | 11.22B |
| Eli Lilly and Co | 2.928B |
| Moderna Inc | 8.604B |
| Amgen Inc | 10.94B |
| Gilead Sciences Inc | 7.264B |